BIOMAT Database Logo BIOMAT Database Logo

Esperamicins, a class of potent antitumor antibiotics: mechanism of action. 1989

B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
Bristol-Myers Corp., Pharmaceutical Research and Development Division, Wallingford, CT 06492-7660.

The esperamicins represent a class of antitumor antibiotics characterized by an unusual chemical core structure and extremely potent cytotoxicity. The mechanism by which these drugs produce cytotoxicity was investigated and found to be related to the formation of single- and double-strand DNA breaks. Using five structurally related analogs, we defined a structure-activity relationship for cytotoxicity in various eukaryotic and DNA-repair-deficient prokaryotic cell lines, for DNA breakage in a human colon carcinoma cell line, and for DNA breakage in vitro in pBR322 DNA. Mild reducing agents such as dithiothreitol greatly increased the DNA breakage potency of these analogs in vitro. Results suggest that the pendant aromatic chromophore of esperamicin A1 may contribute to the uptake of the drug into cells but may also hinder double-strand DNA break formation. Little DNA breakage specificity was observed for the drug in a 139-base-pair fragment of pBR322 DNA. Evidence supports a previously proposed mechanism whereby esperamicins may produce the observed DNA breaks through reduction of the methyl trisulfide group to a thiolate anion followed by a Michael addition of the anion across the alpha,beta-unsaturated ketone. This addition may result in the saturation of the bridgehead double bond, thus allowing the two triple bonds to approach each other, causing cyclization of the diyn-ene to form a phenylene diradical. It is likely that this diradical is the active form of the drug responsible for single- and double-strand DNA breakage produced by this class of antitumor agents.

UI MeSH Term Description Entries
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
Esperamicins, a novel class of potent antitumor antibiotics. I. Physico-chemical data and partial structure.
November 1985, The Journal of antibiotics,
B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
Carbapenems: a potent class of antibiotics.
January 2008, Expert opinion on pharmacotherapy,
B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
Analysis of the mechanism of action of potent antibacterial hetero-tri-organometallic compounds: a structurally new class of antibiotics.
July 2013, ACS chemical biology,
B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
New fluoroquinolones: a class of potent antibiotics.
November 2005, Mini reviews in medicinal chemistry,
B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
Acylfulvenes, a new class of potent antitumor agents.
January 1996, Experientia,
B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
Pradimicin, a novel class of potent antifungal antibiotics.
November 1988, The Journal of antibiotics,
B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
September 2001, Current pharmaceutical design,
B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
The chemistry, mechanism of action and biological properties of CC-1065, a potent antitumor antibiotic.
March 1986, The Journal of antibiotics,
B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
[Role of the adrenal glands in the cytostatic action mechanism of antitumor antibiotics].
April 1978, Antibiotiki,
B H Long, and J Golik, and S Forenza, and B Ward, and R Rehfuss, and J C Dabrowiak, and J J Catino, and S T Musial, and K W Brookshire, and T W Doyle
[Action mechanism of antibiotics].
October 1971, Deutsches medizinisches Journal,
Copied contents to your clipboard!